# Robert Adelman

Robert Adelman of San Francisco, CA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 14 filing roles across Form D (11), Form 13F (2), Form ADV (1).

## Filings (14)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| 2025-03-07 | Form ADV | [VENBIO PARTNERS LLC](https://search.stillhousedata.com/firm/290045) | LIMITED PARTNER | SAN FRANCISCO, CA |
| 2023-02-14 | Form 13F | [venBio Partners LLC](https://search.stillhousedata.com/firm/290045) | Manager | SAN FRANCISCO, CA |
| 2019-02-14 | Form 13F | [venBio Partners L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1737053&type=&dateb=&owner=include&count=40) | Member of the General Partner | SAN FRANCISCO, CA |
| 2009-09-09 | Form D | [Cerimon Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1329473&type=&dateb=&owner=include&count=40) | Director | SOUTH SAN FRANCISCO, CA |
| 2016-10-11 | Form D | [Avoro Life Sciences Offshore Fund Ltd.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1498990&type=&dateb=&owner=include&count=40) | Executive Officer | NEW YORK, NY |
| 2016-10-11 | Form D | [Avoro Life Sciences Fund LLC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1498991&type=&dateb=&owner=include&count=40) | Executive Officer | NEW YORK, NY |
| 2013-10-29 | Form D | [venBio Global Strategic Fund, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1504130&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2012-06-06 | Form D | [Sientra, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1551693&type=&dateb=&owner=include&count=40) | Director | Santa Barbara, CA |
| 2015-12-30 | Form D | [Solstice Biologics LLC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1564178&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2017-03-02 | Form D | [venBio Global Strategic Fund II L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1634632&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2019-03-15 | Form D | [PRECISION BIOSCIENCES INC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1357874&type=&dateb=&owner=include&count=40) | Director | DURHAM, NC |
| 2018-06-20 | Form D | [Metacrine, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1634379&type=&dateb=&owner=include&count=40) | Director | San Diego, CA |
| 2020-03-26 | Form D | [venBio Global Strategic Fund III, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739920&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2021-05-14 | Form D | [venBio Global Strategic Fund IV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1862109&type=&dateb=&owner=include&count=40) | Executive Officer | San Francisco, CA |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
